Carlyle Group & Capital Group Reduce Stakes in Indian Healthcare Firms
Carlyle Group, through its affiliate CA Dawn Investments, sold a 4.3% stake in healthcare tech firm Indegene in an open market transaction for INR 636.17 Cr.
Global investment firm Carlyle Group and financial services company Capital Group have recently reduced their holdings in Indian healthcare technology firms through significant open market transactions.
Carlyle Group, through its affiliate CA Dawn Investments, divested a 4.3% stake in healthcare tech firm Indegene for INR 636.17 Cr via an open market transaction.
According to National Stock Exchange (NSE) bulk deal data, the sale involved 1,02,63,785 shares at an average price of INR 619.82 per share. Following this transaction, Carlyle's stake in Indegene has dropped from 14.52% to 10.22%.
Details of the buyers were not disclosed on the exchange. Shares of Indegene responded negatively to the news, plunging 6.06% to close at INR 627 apiece on the NSE.
Capital Group Trims Holding in Medi Assist Healthcare Services
In separate transactions on the NSE and BSE, Capital Group, through its arm, SmallCap World Fund Inc, sold a 2.24% stake in Medi Assist Healthcare Services for nearly INR 93 Cr.
The deal involved the sale of 15.75 lakh shares at an average price of INR 588 each, bringing the total transaction value to INR 92.65 Cr. Post-sale, Capital Group’s stake in Medi Assist has reduced from 2.93% to 0.7%.
As with Indegene, details of the buyers were unavailable. Shares of Medi Assist Healthcare Services showed marginal movement, rising 0.18% to INR 588.20 on the BSE while closing 0.06% lower at INR 586.20 on the NSE.
While Carlyle and Capital Group have reduced exposure, the healthcare sector continues to attract investor interest, given its strong growth potential in India.
Stay tuned for more such updates on Digital Health News.
